Summit Therapeutics has submitted a Biologics License Application to the FDA for ivonescimab, a first-in-class bispecific ...

Citi recently upgraded Zoom Communications to Buy from Neutral/High Risk, citing the company’s expanding AI product suite and ...

The White Nevrons are strange when compared to the rest of Clair Obscur: Expedition 33, but should they be spared or killed?

07/03/2025 Petition GRANTED and consolidated with No. 24-1113, limited to the following question: Whether the New Jersey Transit Corporation is an arm of the State of New Jersey for interstate ...

08/01/2024 Motion to extend the time to file a response from August 14, 2024 to October 14, 2024, submitted to The Clerk. 08/02/2024 Motion to extend the time to file a response is granted and the ...